307 related articles for article (PubMed ID: 2476494)
1. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain.
Merryman P; Silver J; Gregersen PK; Solomon G; Winchester R
J Immunol; 1989 Sep; 143(6):2068-73. PubMed ID: 2476494
[TBL] [Abstract][Full Text] [Related]
2. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide sequence of a DRw10 beta chain cDNA clone. Identity of the third D region with that of the DRw53 allele of the beta 2 locus and as the probable site encoding a polymorphic MHC class II epitope.
Merryman P; Gregersen PK; Lee S; Silver J; Nuñez-Roldan A; Crapper R; Winchester R
J Immunol; 1988 Apr; 140(7):2447-52. PubMed ID: 2450924
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the HLA class II genes in two DRw6-related haplotypes, DRw13 DQw1 and DRw14 DQw3.
Kao HT; Gregersen PK; Tang JC; Takahashi T; Wang CY; Silver J
J Immunol; 1989 Mar; 142(5):1743-7. PubMed ID: 2493052
[TBL] [Abstract][Full Text] [Related]
5. Recombination sites in the HLA class II region are haplotype dependent.
Gregersen PK; Kao H; Nunez-Roldan A; Hurley CK; Karr RW; Silver J
J Immunol; 1988 Aug; 141(4):1365-8. PubMed ID: 3135331
[TBL] [Abstract][Full Text] [Related]
6. Identification of the DRw10 DR beta 1-chain allele as encoding a polymorphic class II major histocompatibility complex epitope otherwise restricted to DR beta 2 molecules of the DRw53 type.
Matsuyama T; Winchester R; Lee S; Shookster L; Nunez-Roldan A
J Immunol; 1988 Jan; 140(2):537-43. PubMed ID: 2447181
[TBL] [Abstract][Full Text] [Related]
7. Recombination between DQ alpha and DQ beta genes generates human histocompatibility leukocyte antigen class II haplotype diversity.
Song QL; Gregersen PK; Karr RW; Silver J
J Immunol; 1987 Nov; 139(9):2993-5. PubMed ID: 3117885
[TBL] [Abstract][Full Text] [Related]
8. Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype.
Karr RW; Gregersen PK; Obata F; Goldberg D; Maccari J; Alber C; Silver J
J Immunol; 1986 Nov; 137(9):2886-90. PubMed ID: 3020127
[TBL] [Abstract][Full Text] [Related]
9. Characterization of specific HLA-DQ alpha allospecificities by genomic, biochemical, and serologic analysis.
Amar A; Radka SF; Holbeck SL; Kim SJ; Nepom BS; Nelson K; Nepom GT
J Immunol; 1987 Jun; 138(11):3986-90. PubMed ID: 2438332
[TBL] [Abstract][Full Text] [Related]
10. Molecular variation of human major histocompatibility complex DQw3 beta-chains.
So AK; Lindsay J; Bodmer J; Trowsdale J
J Immunol; 1987 Nov; 139(10):3506-11. PubMed ID: 2890689
[TBL] [Abstract][Full Text] [Related]
11. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
13. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
Gebuhrer L; Betuel H; Lambert J; Freidel AC; Farre A
Hum Immunol; 1987 Mar; 18(3):235-45. PubMed ID: 2437088
[TBL] [Abstract][Full Text] [Related]
14. Definition of DRw10 specificity by restriction fragment length polymorphism.
Semana G; Bignon JD; Quillivic F; Cheneau ML; Herniou E; Muller JY; Genetet B; Fauchet R
Tissue Antigens; 1988 Sep; 32(3):113-20. PubMed ID: 2464202
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype.
Hatae K; Kimura A; Okubo R; Watanabe H; Erlich HA; Ueda K; Nishimura Y; Sasazuki T
Eur J Immunol; 1992 Jul; 22(7):1899-905. PubMed ID: 1352502
[TBL] [Abstract][Full Text] [Related]
17. Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta.
MacMurray AJ; Bell JI; Denney D; Watling D; Foster LS; McDevitt HO
J Immunol; 1987 Jul; 139(2):574-86. PubMed ID: 2885374
[TBL] [Abstract][Full Text] [Related]
18. DR and DQ beta cDNA sequences associated with a DR2 haplotype.
Hurley CK; Ziff BL; Steiner N; Gregersen PK; Silver J
Hum Immunol; 1988 Jul; 22(3):179-83. PubMed ID: 3139589
[TBL] [Abstract][Full Text] [Related]
19. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
20. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
